Skip to main content
AmigoFish

Ep. 78 - Biotech’s New Normal: SR One’s Simeon George on Adapting to Market Constraints

From The BioCentury Show · · 31 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Biotechs need to get used to the new normal, says SR One CEO and Managing Partner Simeon George, and that will require significant adjustments to the business model. This new normal comes from an extended tough capital environment against a backdrop of political uncertainty, but while biotechs face a different set of factors than they have in the past, there are still first principles of value creation that should guide them. George, who co-founded SR One management in 2020 following its spinout from GSK, spoke on The BioCentury Show with Editor in Chief Simone Fishburn about the challenges facing biotechs and how VCs are navigating through the complexity of the moment. He also discussed SR One’s strategy and philosophy of investing.

View full story: https://www.biocentury.com/article/655142

00:00 - Introduction 01:31 - Meeting the Moment 04:45 - Company Valuations 13:54 - China Strategy, NewCos 22:08 - Building Successful Biotechs

#biotech #biopharma #pharma #lifescience #CEO #financing #newco

Back to The BioCentury Show · Report a problem